Provided by Tiger Trade Technology Pte. Ltd.

Glaukos

181.39
-4.2600-2.29%
Post-market: 181.390.00000.00%19:35 EDT
Volume:639.69K
Turnover:116.25M
Market Cap:10.70B
PE:-55.89
High:187.14
Open:186.21
Low:179.20
Close:185.65
52wk High:191.62
52wk Low:73.16
Shares:58.98M
Float Shares:56.44M
Volume Ratio:1.07
T/O Rate:1.13%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.2456
EPS(LYR):-3.2819
ROE:-25.98%
ROA:-5.18%
PB:15.68
PE(LYR):-55.27

Loading ...

Stifel Nicolaus Sticks to Their Buy Rating for Glaukos (GKOS)

TIPRANKS
·
Jul 28

Glaukos Completes Enrollment in 510(k) Pivotal Study of Preserflo MicroShunt for Advanced Glaucoma Patients

Reuters
·
Jul 27

Glaukos Announces Completion of Patient Enrollment in 510(k) Pivotal Study for Preserflo™ Microshunt

THOMSON REUTERS
·
Jul 27

Earning Preview: Glaukos revenue is expected to increase by 30.68% this quarter, and institutional views are bullish

Earnings Agent
·
Jul 22

Glaukos CFO Alex R. Thurman Disposes of USD 1.6 Million in Common Shares

Reuters
·
Jul 22

Glaukos (GKOS) Could Be 1% Undervalued After Its Pipeline Growth Narrative

Simply Wall St.
·
Jul 17

Glaukos is Maintained at Buy by Truist Securities

Dow Jones
·
Jul 17

Truist Adjusts Price Target on Glaukos to $180 From $160, Maintains Buy Rating

MT Newswires Live
·
Jul 16

Mobia Medical Names Reza Zadno to Board as Independent Director

Reuters
·
Jul 16

Glaukos CFO Alex R. Thurman Sells 10,000 Shares for $1.55 Million

Reuters
·
Jul 14

Glaukos Chief Development Officer Tomas Navratil Disposes of 716 Shares for $99,571.96

Reuters
·
Jul 09

Glaukos is Maintained at Buy by Citigroup

Dow Jones
·
Jul 08

Press Release: Glaukos to Release Second Quarter 2026 Financial Results After Market Close on July 29

Dow Jones
·
Jul 08

Glaukos price target raised to $175 from $162 at Citi

TIPRANKS
·
Jul 08

Glaukos: Favorable iDose Reimbursement Outlook and Epioxa Launch Drive Attractive Risk-Reward, Supporting Buy Rating

TIPRANKS
·
Jul 08

Citi Sticks to Its Buy Rating for Glaukos (GKOS)

TIPRANKS
·
Jul 08

Glaukos Initiated at Buy by HC Wainwright & Co.

Dow Jones
·
Jul 06

Glaukos Corporation : H.c. Wainwright Initiates Coverage with Buy Rating and Target Price $168

THOMSON REUTERS
·
Jul 06

Glaukos Price Target Maintained with a $165.00/share by Piper Sandler

Dow Jones
·
Jul 01

Analysts Conflicted on These Healthcare Names: Alumis Inc. (ALMS), Glaukos (GKOS) and Regeneron (REGN)

TIPRANKS
·
Jul 01